Metabolon Logo
Metabolon Logo

The Alzheimer’s disease drug candidate J147 decreases blood plasma fatty acid levels via modulation of AMPK/ACC1 signaling in the liver

Author: D Kepchia, L Huang, A Currais, Z Liang, et al.
Year Published: 2022
Media Outlet: Biomedicine & Pharmacotherapy

Open Access? Yes

Matrix: Plasma and Serum
Biological Themes: Liver function
Product(s): Global Discovery Panel
Metabolon PUBLICATION
Cited in over 3,000 publications, we help scientists and manufacturers gain greater insight into their studies through metabolomics.

Contact Us

Talk with an expert

Request a quote for our services, get more information on sample types and handling procedures, request a letter of support, or submit a question about how metabolomics can advance your research.

Corporate Headquarters

617 Davis Drive, Suite 100
Morrisville, NC 27560

Mailing Address:
P.O. Box 110407
Research Triangle Park, NC 27709

+1 (919) 572-1721